Literature DB >> 26408548

Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys.

Edmond K Obeng-Gyimah1, Rajat Deo2.   

Abstract

Keywords:  chronic kidney disease; echocardiography; electrophysiology; heart failure

Mesh：

Year:  2015        PMID： 26408548      PMCID： PMC4594077          DOI： 10.2215/CJN.09120815

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  16 in total

1.  Relation between renal function and response to cardiac resynchronization therapy in Multicenter Automatic Defibrillator Implantation Trial--Cardiac Resynchronization Therapy (MADIT-CRT).

Authors:  Ilan Goldenberg; Arthur J Moss; Scott McNitt; Alon Barsheshet; Daniel Gray; Mark L Andrews; Mary W Brown; Wojciech Zareba; Edward Sze; Scott D Solomon; Marc A Pfeffer
Journal:  Heart Rhythm       Date:  2010-09-15       Impact factor: 6.343

2.  Cardiac Resynchronization Therapy in CKD Stage 4 Patients.

Authors:  Ulas Höke; Mand J H Khidir; Enno T van der Velde; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-25       Impact factor: 8.237

3.  Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy.

Authors:  Rutger J Van Bommel; Sjoerd A Mollema; C Jan Willem Borleffs; Matteo Bertini; Claudia Ypenburg; Nina Ajmone Marsan; Victoria Delgado; Ernst E Van Der Wall; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2011-02-01       Impact factor: 24.094

4.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Andrew E Epstein; John P DiMarco; Kenneth A Ellenbogen; N A Mark Estes; Roger A Freedman; Leonard S Gettes; A Marc Gillinov; Gabriel Gregoratos; Stephen C Hammill; David L Hayes; Mark A Hlatky; L Kristin Newby; Richard L Page; Mark H Schoenfeld; Michael J Silka; Lynne Warner Stevenson; Michael O Sweeney
Journal:  Circulation       Date:  2012-12-19       Impact factor: 29.690

5.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction.

Authors:  D L Dries; D V Exner; M J Domanski; B Greenberg; L W Stevenson
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

6.  Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control.

Authors:  Nisha I Parikh; Shih-Jen Hwang; Martin G Larson; James B Meigs; Daniel Levy; Caroline S Fox
Journal:  Arch Intern Med       Date:  2006-09-25

7.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.

Authors:  A Al-Ahmad; W M Rand; G Manjunath; M A Konstam; D N Salem; A S Levey; M J Sarnak
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

8.  Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.

Authors:  Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Journal:  Circulation       Date:  2006-02-07       Impact factor: 29.690

9.  Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate.

Authors:  Guido Boerrigter; Lisa C Costello-Boerrigter; William T Abraham; Martin G St John Sutton; Denise M Heublein; Kristin M Kruger; Michael R S Hill; Peter A McCullough; John C Burnett
Journal:  J Card Fail       Date:  2008-05-27       Impact factor: 5.712

10.  Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study.

Authors:  Jehu Mathew; Ronit Katz; Martin St John Sutton; Sanjay Dixit; Edward P Gerstenfeld; Stefano Ghio; Michael R Gold; Cecilia Linde; Michael G Shlipak; Rajat Deo
Journal:  Eur J Heart Fail       Date:  2012-09-06       Impact factor: 15.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.